Apellis Pharmaceuticals
Developing transformative therapies targeting C3
- B2B
About Apellis Pharmaceuticals
Developing transformative therapies targeting the complement system's C3 to treat diseases in ophthalmology, nephrology, hematology, and neurology with broad platform potential
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Waltham, Massachusetts, United States
- Founded
- 2008
- Revenue
- $1BFY2025, publicly reported
- Website
- apellis.com
- linkedin.com/company/apellis
Apellis Pharmaceuticals at a glance
Apellis Pharmaceuticals is a B2B company in the Biotechnology Research industry, headquartered in Waltham, Massachusetts, United States.
Apellis Pharmaceuticals was founded in 2008.
Apellis Pharmaceuticals has 251–1,000 employees.
Apellis Pharmaceuticals's revenue is $1B (FY2025, publicly reported).
Frequently asked questions about Apellis Pharmaceuticals
What is Apellis Pharmaceuticals's revenue?
Apellis Pharmaceuticals's revenue is $1B (FY2025, publicly reported).
How many employees does Apellis Pharmaceuticals have?
Apellis Pharmaceuticals has 251–1,000 employees.
Where is Apellis Pharmaceuticals headquartered?
Apellis Pharmaceuticals is headquartered in Waltham, Massachusetts, United States.
Selling to companies like Apellis Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies